+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Breast Reconstruction Market by Product, Shape, End User, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717240
The breast reconstruction market size is estimated to be USD 547.1 million in 2022 and is expected to witness a CAGR of 6.87% during the forecast period 2023-2033. Rise in incidence of breast cancer patients and existence of advantageous reimbursement rules are some of the factors contributing to the market growth. Furthermore, increase in breast reconstruction surgeries, and global adoption of technologically advanced products are other factors supporting the market growth. However, presence of alternative methods and risk associated with the procedures is expected to hinder the growth.

Existence of advantageous reimbursement rules is expected to fuel the market growth during the forecast period. For instance, according to a study by ScienceDirect, the average reimbursement rate for pedicled flaps was estimated to be USD 5,993.16, while the same figure for free flaps was USD 4,325.84. Additionally, according to a comparable source, reimbursement for breast reconstructions was similarly based on the method across European nations. Furthermore, Medicare states that if a person has had a breast mastectomy due to breast cancer, breast reconstruction can be covered. In addition, according to Services Australia, the external breast prosthesis reimbursement programme can pay for breast prosthesis after breast cancer.

Rise in incidence of breast cancer patients is predicted to propel the market growth during the projected period. For instance, the WHO estimates that in 2020, breast cancer would be diagnosed in about 2.3 million women worldwide. A total of 55,900 cases of breast cancer are identified each year in the U.K. alone, according to Cancer Research U.K. In addition, a comparable source claims that breast cancer is the most prevalent kind of cancer in the United Kingdom. Similar to the United States, the United Kingdom expects one in seven women to receive a breast cancer diagnosis. As a result, it is anticipated that the demand for breast reconstruction can rise as a result of the surge in the number of breast cancer patients, driving the market's growth over the forecast period.

Segmentation

By Product

The market is categorized into acellular dermal matrix, implants, and tissue expander. In 2022, the implants segment accounted for the highest revenue share due to the increasing usage of breast implants in breast augmentation procedures. For instance, the NCBI estimates that around 8.08 women per 1,000 in the U.S. have some type of breast implant. Furthermore, according to the University of Utah Health, almost 35 million women have textured breast implants, according to a similar source, it is estimated that over 1.5 million women get implants annually. The implant segment is therefore expected to dominate the industry in the years to come. The tissue expander segment is anticipated to increase at the fastest rate over the projection period due to rising usage of tissue expanders for breast reconstruction. For instance, research by Science Direct found that up to 65% of all breast reconstruction procedures involved tissue expander reconstruction. Tissue expanders make breast reconstruction faster, easier, and substantially less expensive. In contrast to tissue repair, which requires abdominal muscle or tissue to complete the treatment, driving segment growth, it is also suitable for all types of women.

By Shape

The market is divided into anatomical shape and round shape. In the global market, the round shape segment accounted for the largest revenue share in 2022 owing to the increase in product introductions, the FDA's frequent updates on the safety of breast implants, and the implementation of several clinical investigations. For instance, GC Aesthetics will introduce the PERLE, a new generation of round silicone breast implants, in May 2021. In order to ensure that patients undergoing breast implant surgery have enough information, the U.S. FDA amended its safety guidelines for breast implants in October 2021 and prohibited the sales and distribution of breast implants. Therefore, round-shaped breast implants are anticipated to experience significant increase as a result of the aforementioned factors. The increase can be attributed to a number of benefits of breast implants with anatomical shapes. For instance, these breast implants, according to Sayah Institute, have a natural form and textured surface, preventing the implant from shifting after implantation. The segment is growing due to their texture, which makes them perfect for breast augmentation in ladies with limited natural breast tissue.

By End User

The market is segmented into ambulatory surgical centers, hospitals, and cosmetology clinics. In 2022, the segment accounted for the largest revenue share owing to increase in hospitals around the world. For instance, the Athar Institute of Health Management & Studies estimates that hospitals in India account for 80% of the country's overall healthcare sector. Additionally, according to The Canadian Encyclopedia, Canada has 193 private hospitals in addition to 706 public hospitals. Additionally, medical tourism has grown significantly on a global scale. The quality of healthcare services offered by hospitals is anticipated to improve as medical tourism grows. Therefore, it is predicted that the hospitals segment is expected to have considerable increase throughout the projection period as a result of the aforementioned factors. The ambulatory surgical centres are expected to increase at the fastest pace over the forecast period. The rise in breast reconstruction procedures performed in ASCs around the world is responsible for the expansion. For instance, approximately 1,692,717 breast reconstruction procedures were carried out in ASCs, according to the Plastic Surgery Statistics Report.

Regional Markets

In 2022, North America region accounted for the highest revenue in the breast reconstruction market and is expected to maintain its dominance during the forecast period. This is attributed to the high prevalence of breast cancer in this region. For instance, according to the Canadian Cancer Society, every day 78 Canadian women are diagnosed with breast cancer, but only 15 of them die from the disease. Additionally, according to a related source, 28,600 Canadian women are expected to receive a breast cancer diagnosis in 2022. 25% of all new instances of cancer fall under this figure. Therefore, it is anticipated that the above factors will accelerate market growth in the North American region. The Asia Pacific region is anticipated to experience the fastest CAGR over the projection period. For instance, the NCBI data revealed that there were approximately 303,600 new instances of breast cancer and 70,400 deaths from the disease in China. Furthermore, according to a similar source, the incidence rate and death rate in China are predicted to rise by 2030 due to shifting demographics and risks. More than 76.5% of women preferred breast reconstruction post mastectomy, according to research by a similar source. As a result, the market is anticipated to increase significantly during the next years.

Competitor Insights

Some of the key players operating in the breast reconstruction market are Sientra Inc., Johnson & Johnson, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical Holdings, Allergan Inc., Sebbin, Integra LifeSciences, Ideal Implant Incorporated, and GC Aesthetics.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

In October 2021, Sientra and Mission Plasticos introduced 'RESHAPING LIVES FULL CIRCLE,' a great program that offers post-mastectomy reconstructive breast surgery to women who live below the poverty line. It is also supported by a USD 1 million contribution from Sientra.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, shape, and end user from 2023 to 2033.

Segmentation: Breast Reconstruction Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Acellular Dermal Matrix

Implants

  • Air Tissue Expander
  • Saline Expander

Tissue Expander

  • Saline Breast Implants
  • Silicone Breast Implants

Shape (Revenue, USD Million), 2022 - 2033

  • Anatomical Shape
  • Round Shape

End user (Revenue, USD Million), 2022 - 2033

  • Ambulatory Surgical Centers
  • Hospitals
  • Cosmetology Clinics

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Breast Reconstruction

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Breast Reconstruction Market

7. Market Analysis by Product
7.1. Acellular Dermal Matrix
7.1.1. Acellular Dermal Matrix Market Forecast, 2022-2033 (USD Million)
7.2. Implants
7.2.1. Implants Market Forecast, 2022-2033 (USD Million)
7.2.1.1. Air Tissue Expander
7.2.1.1.1. Air Tissue Expander Market Forecast, 2022-2033 (USD Million)
7.2.1.2. Saline Expander
7.2.1.2.1. Saline Expander Market Forecast, 2022-2033 (USD Million)
7.3. Tissue Expander
7.3.1. Tissue Expander Market Forecast, 2022-2033 (USD Million)
7.3.1.1. Saline Breast Implants
7.3.1.1.1. Saline Breast Implants Market Forecast, 2022-2033 (USD Million)
7.3.1.2. Silicone Breast Implants
7.3.1.2.1. Silicone Breast Implants Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Shape
8.1. Anatomical Shape
8.1.1. Anatomical Shape Market Forecast, 2022-2033 (USD Million)
8.2. Round Shape
8.2.1. Round Shape Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by End User
9.1. Ambulatory Surgical Centers
9.1.1. Ambulatory Surgical Centers Market Forecast, 2022-2033 (USD Million)
9.2. Hospitals
9.2.1. Hospitals Market Forecast, 2022-2033 (USD Million)
9.3. Cosmetology Clinics
9.3.1. Cosmetology Clinics Market Forecast, 2022-2033 (USD Million)

10. Regional Market Analysis
10.1. Regional Market Trends Analysis

11. North America Breast Reconstruction Market
11.1. North America Breast Reconstruction Market
11.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.2. U.S. Breast Reconstruction Market
11.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.3. Canada Breast Reconstruction Market
11.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

12. Europe Breast Reconstruction Market
12.1. Europe Breast Reconstruction Market
12.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.2. Germany Breast Reconstruction Market
12.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.3. UK Breast Reconstruction Market
12.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.4. France Breast Reconstruction Market
12.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.5. Spain Breast Reconstruction Market
12.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.6. Italy Breast Reconstruction Market
12.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.7. Rest of Europe Breast Reconstruction Market
12.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
12.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

13. Asia Pacific Breast Reconstruction Market
13.1. Asia Pacific Breast Reconstruction Market
13.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.2. Japan Breast Reconstruction Market
13.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.3. China Breast Reconstruction Market
13.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.4. India Breast Reconstruction Market
13.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.5. South Korea Breast Reconstruction Market
13.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.6. Australia Breast Reconstruction Market
13.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
13.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.6.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.7. Rest of Asia Pacific Breast Reconstruction Market
13.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
13.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.7.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
13.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

14. Latin America Breast Reconstruction Market
14.1. Latin America Breast Reconstruction Market
14.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
14.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.2. Brazil Breast Reconstruction Market
14.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
14.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.3. Mexico Breast Reconstruction Market
14.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
14.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.4. Argentina Breast Reconstruction Market
14.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
14.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.5. Rest of Latin America Breast Reconstruction Market
14.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
14.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.5.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
14.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

15. MEA Breast Reconstruction Market
15.1. MEA Breast Reconstruction Market
15.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
15.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
15.1.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
15.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
15.2. GCC Breast Reconstruction Market
15.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
15.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
15.2.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
15.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
15.3. South Africa Breast Reconstruction Market
15.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
15.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
15.3.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
15.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
15.4. Rest of MEA Breast Reconstruction Market
15.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
15.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
15.4.1.2. Market Size and Forecast by Shape, 2022-2033 (USD Million)
15.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

16. Competitor Analysis
16.1. Market Share Analysis, 2022
16.2. Major Recent Developments, 2019-2022

17. Company Profiles
17.1. Sientra Inc.
17.1.1. Company Snapshot
17.1.2. Company Overview
17.1.3. Financial Analysis
17.1.4. Product Benchmarking
17.1.5. Recent Developments
17.2. Johnson & Johnson
17.2.1. Company Snapshot
17.2.2. Company Overview
17.2.3. Financial Analysis
17.2.4. Product Benchmarking
17.2.5. Recent Developments
17.3. Establishment Labs S. A.
17.3.1. Company Snapshot
17.3.2. Company Overview
17.3.3. Financial Analysis
17.3.4. Product Benchmarking
17.3.5. Recent Developments
17.4. POLYTECH Health & Aesthetics GmbH
17.4.1. Company Snapshot
17.4.2. Company Overview
17.4.3. Financial Analysis
17.4.4. Product Benchmarking
17.4.5. Recent Developments
17.5. RTI Surgical Holdings
17.5.1. Company Snapshot
17.5.2. Company Overview
17.5.3. Financial Analysis
17.5.4. Product Benchmarking
17.5.5. Recent Developments
17.6. Allergan Inc.
17.6.1. Company Snapshot
17.6.2. Company Overview
17.6.3. Financial Analysis
17.6.4. Product Benchmarking
17.6.5. Recent Developments
17.7. Sebbin
17.7.1. Company Snapshot
17.7.2. Company Overview
17.7.3. Financial Analysis
17.7.4. Product Benchmarking
17.7.5. Recent Developments
17.8. Integra LifeSciences
17.8.1. Company Snapshot
17.8.2. Company Overview
17.8.3. Financial Analysis
17.8.4. Product Benchmarking
17.8.5. Recent Developments
17.9. Ideal Implant Incorporated
17.9.1. Company Snapshot
17.9.2. Company Overview
17.9.3. Financial Analysis
17.9.4. Product Benchmarking
17.9.5. Recent Developments
17.10. GC Aesthetics
17.10.1. Company Snapshot
17.10.2. Company Overview
17.10.3. Financial Analysis
17.10.4. Product Benchmarking
17.10.5. Recent Developments
17.11. Company 11
17.11.1. Company Snapshot
17.11.2. Company Overview
17.11.3. Financial Analysis
17.11.4. Product Benchmarking
17.11.5. Recent Developments
17.12. Company 12
17.12.1. Company Snapshot
17.12.2. Company Overview
17.12.3. Financial Analysis
17.12.4. Product Benchmarking
17.12.5. Recent Developments
17.13. Company 13
17.13.1. Company Snapshot
17.13.2. Company Overview
17.13.3. Financial Analysis
17.13.4. Product Benchmarking
17.13.5. Recent Developments
17.14. Company 14
17.14.1. Company Snapshot
17.14.2. Company Overview
17.14.3. Financial Analysis
17.14.4. Product Benchmarking
17.14.5. Recent Developments
17.15. Company 15
17.15.1. Company Snapshot
17.15.2. Company Overview
17.15.3. Financial Analysis
17.15.4. Product Benchmarking
17.15.5. Recent Developments

18. Conclusion

19. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sientra Inc.
  • Johnson & Johnson
  • Establishment Labs S.A.
  • POLYTECH Health & Aesthetics GmbH
  • RTI Surgical Holdings
  • Allergan Inc.
  • Sebbin
  • Integra LifeSciences
  • Ideal Implant Incorporated
  • GC Aesthetics